US FDA's Device-Focused Patient Engagement AdComm Tackles Trial Challenges

FDA's new Patient Engagement Advisory Committee will discuss patient perspectives on device clinical trials at its first scheduled meeting.

More from Regulation

More from Policy & Regulation